Newsroom

LONDON--(BUSINESS WIRE)--  TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Oberon AIM VCT plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer   2. Reason for the notification (please mark the appropri...

MUNICH--(BUSINESS WIRE)--TASKING, a global leader in high-performance embedded software development tools, today announced a tighter integration between its unified toolchain and WITTENSTEIN high integrity systems (WHIS)’s pre-certified safety real-time operating system SAFERTOS®. By using TASKING’s embedded software trace tool (SWAT), developers can perform comprehensive OS-aware timing analysis without requiring dedicated on-chip hardware trace support. In safety-critical embedded systems, pr...

DENVER--(BUSINESS WIRE)--Object First, the ransomware-proof on-premises backup storage company, today published a commissioned study conducted by analyst firm Omdia that found 83% of organizations have fallen victim to a successful ransomware attack in the last 24 months. The results also show that it’s harder to recover from attacks: only 39% of organizations recovered at least 75% of their data after an attack, down from the 57% in 2024. The survey reinforces that outages from ransomware are...

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), a clinical-stage biotechnology company developing next-generation targeted radiopharmaceuticals, today announced that Pharma Tech Outlook has named MTTI its Radiopharmaceutical Therapy Solution of the Year 2026, recognizing EvaThera™, MTTI’s proprietary pharmacokinetic engineering platform based on Evans Blue (EB)-mediated reversible albumin binding. The recognition highlights EvaThera™’s differentiated approach...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Airrived, the company behind the enterprise Agentic OS, today announced the launch of its Sovereign AI Platform, giving governments and enterprises a way to run agentic AI entirely inside their own environments — with nothing required to leave the building. Airrived will showcase the platform live at GISEC Global, taking place 16–18 September 2026 at the Dubai Exhibition Centre (DEC), Expo City, Dubai. As AI adoption accelerates, a harder question i...

OMAHA, Neb.--(BUSINESS WIRE)--ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, today announced it has entered into a definitive agreement to acquire Cranium Ventures, a privately held developer of cloud-native card payment switching technology. The technology will be added to ACI Connetic for Cards, which ACI launched in March 2026. ACI Connetic is the platform behind ACI’s intelligent payments orchestration strategy, introduced in 2025 as the industry’s first...

DALLAS--(BUSINESS WIRE)--Hikino AI today announced RAV for iOS, extending the Revenue Control Plane to the one place channel revenue happens: in front of the customer. With RAV for iOS, sales reps process orders the way they talk, and the first order is already through.Amza Safi, Sales Director West at Clutch Solutions, placed the first verbally processed, agentic AI customer order from his iPhone with zero humans touching a keyboard. He described the order out loud, the way he would brief a col...

WALTHAM, Mass.--(BUSINESS WIRE)--Netcracker and GFiber receive the TM Forum Excellence in Customer and Developer Experience award....

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of new data in Blood Neoplasia, validating the prognostic and predictive value of Signatera in patients with both newly diagnosed and relapsed/refractory (R/R) lymphoma. PET/CT scans serve as the standard tool for assessing treatment response in lymphoma, but their performance is limited, with positive predictive value (PPV) reported as low as 50%...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026, with a fireside chat at 11:30 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. An archived webcast will be available on the Company’s website. About BeOne Medicin...